Division of Imaging and Technology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Sweden.
Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.
Acta Neurochir (Wien). 2024 Nov 4;166(1):438. doi: 10.1007/s00701-024-06312-7.
Autologous bone cranioplasty is associated with a high complication rate, particularly infections and bone resorption. Although there are studies on the incidence and risk factors for complications following autologous bone cranioplasty, the study design is typically limited to retrospective analysis with multiple statistical explorations in small cohorts from single centers. Thus, there is a need for systematic analysis of aggregated data to determine the rate and risk factors for cranioplasty complications.
To determine the incidence and risk factors for complications after autologous bone cranioplasty.
In this systemic review, we conducted a Medline, Embase, Cochrane, and Web of Science search: 11,172 papers were identified. Duplicates were removed and only articles on complications following autologous bone cranioplasty between the years 2000 and 2022 were included. After title, abstract, and article screening, 132 papers were included for further analysis.
In total, the 132 studies are based on 13,592 patients (14960 implants). One third of the studies include patients with less than 3 months of postoperative follow-up. Complication management (flap removal, revision without flap removal, and conservative treatment) of infection, bone resorption, and hematoma/seromas are not reported in 19-30% of the studies. In the studies with defined complications management, the overall complication rate is 7.6% (95% Confidence Interval (CI) [7.1-8.2]) for infection, 14.4% (95% CI [13.7-15.2]) for bone resorption with indication for reconstruction, and 5.8%, (95% CI 5.2-6.5) for hematoma/seromas. Factors such as younger age, an extended interval between craniectomy and cranioplasty, the use of a fragmented bone implant, a larger implant size, and shunt treatment are linked to an increased risk of postoperative bone resorption.
The lack of consistent definitions of complications, variations in follow-up time, and small study cohorts limit the external validity of many studies. Overall, the rate of bone flap resorption that required reoperation is high, while the rate of infectious complications is comparable to synthetic implants. Thus, autologous bone should preferably be used in cases without strong risk factors for bone necrosis.
自体骨颅骨修补术的并发症发生率较高,特别是感染和骨吸收。虽然有研究报道了自体骨颅骨修补术后并发症的发生率和危险因素,但研究设计通常仅限于回顾性分析,且来自单一中心的小队列的统计探索较多。因此,需要对汇总数据进行系统分析,以确定颅骨修补并发症的发生率和危险因素。
确定自体骨颅骨修补术后并发症的发生率和危险因素。
在本次系统性回顾中,我们对 Medline、Embase、Cochrane 和 Web of Science 进行了检索:共确定了 11172 篇论文。去除重复项后,仅纳入 2000 年至 2022 年期间关于自体骨颅骨修补术后并发症的文章。经过标题、摘要和文章筛选后,有 132 篇文章被纳入进一步分析。
共有 132 项研究纳入了 13592 例患者(14960 个植入物)。三分之一的研究纳入了术后随访时间少于 3 个月的患者。19%-30%的研究未报告感染、骨吸收和血肿/血清肿的并发症处理(皮瓣去除、无需皮瓣去除的翻修和保守治疗)。在有明确并发症处理的研究中,感染的总体并发症发生率为 7.6%(95%置信区间[7.1-8.2]),有重建指征的骨吸收发生率为 14.4%(95%置信区间[13.7-15.2]),血肿/血清肿的发生率为 5.8%(95%置信区间[5.2-6.5])。年龄较小、颅骨切除术和颅骨修补术之间的间隔时间延长、使用碎骨植入物、植入物尺寸较大和分流治疗等因素与术后骨吸收风险增加相关。
缺乏对并发症的一致定义、随访时间的差异以及小队列研究限制了许多研究的外部有效性。总体而言,需要再次手术的骨瓣吸收发生率较高,而感染性并发症的发生率与合成植入物相当。因此,在没有骨坏死强危险因素的情况下,自体骨应优先使用。